ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,739,599 | +3.4% | 179,702 | +19.0% | 1.26% | +14.4% |
| Q2 2023 | $3,616,450 | -10.9% | 151,000 | -30.1% | 1.10% | -2.8% |
| Q1 2023 | $4,060,800 | +155.4% | 216,000 | +116.0% | 1.13% | +130.8% |
| Q4 2022 | $1,590,000 | +3.7% | 100,000 | +68.0% | 0.49% | +20.9% |
| Q1 2021 | $1,534,000 | -94.1% | 59,514 | -87.8% | 0.41% | -94.3% |
| Q4 2020 | $25,982,000 | +29.6% | 486,000 | 0.0% | 7.10% | +9.6% |
| Q3 2020 | $20,048,000 | +36.4% | 486,000 | +59.3% | 6.47% | +32.5% |
| Q2 2020 | $14,698,000 | +3.3% | 305,000 | -9.5% | 4.89% | -24.7% |
| Q1 2020 | $14,232,000 | -1.0% | 337,000 | +0.3% | 6.49% | +25.3% |
| Q4 2019 | $14,371,000 | +487.5% | 336,000 | +394.1% | 5.18% | +358.1% |
| Q3 2019 | $2,446,000 | +72.9% | 68,000 | +28.3% | 1.13% | +115.2% |
| Q2 2019 | $1,415,000 | -80.4% | 53,000 | -80.3% | 0.52% | -80.3% |
| Q1 2019 | $7,220,000 | +101.7% | 269,000 | -4.6% | 2.67% | +20.1% |
| Q4 2018 | $3,579,000 | +245.8% | 282,065 | +333.9% | 2.22% | +351.4% |
| Q3 2018 | $1,035,000 | +7.7% | 65,000 | +52.0% | 0.49% | +31.2% |
| Q1 2018 | $961,000 | -90.4% | 42,773 | -87.2% | 0.38% | -89.4% |
| Q4 2017 | $10,047,000 | +10.8% | 333,773 | +38.6% | 3.54% | +0.3% |
| Q3 2017 | $9,068,000 | +136.0% | 240,773 | +74.8% | 3.53% | +141.8% |
| Q2 2017 | $3,842,000 | +125.1% | 137,773 | +177.5% | 1.46% | +123.6% |
| Q1 2017 | $1,707,000 | +17.3% | 49,651 | -1.6% | 0.65% | -0.3% |
| Q4 2016 | $1,455,000 | – | 50,458 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |